O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 24 300 KRW -0.61% Market Closed
Market Cap: 929.4B KRW
Have any thoughts about
Oscotec Inc?
Write Note

Relative Value

The Relative Value of one Oscotec Inc stock under the Base Case scenario is 7 768.92 KRW. Compared to the current market price of 24 300 KRW, Oscotec Inc is Overvalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7 768.92 KRW
Overvaluation 68%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
2
Median 3Y
169.9
Median 5Y
128.6
Industry
2.5
Forward
27.5
vs History
vs Industry
Median 3Y
-39.6
Median 5Y
-47.3
Industry
21.8
Forward
-196.4
vs History
vs Industry
Median 3Y
-42.9
Median 5Y
-45.9
Industry
16.1
vs History
vs Industry
Median 3Y
-41
Median 5Y
-48.6
Industry
23.8
vs History
87
vs Industry
3
Median 3Y
11.9
Median 5Y
14.1
Industry
2.1
vs History
93
vs Industry
2
Median 3Y
151.5
Median 5Y
111.9
Industry
2.7
Forward
24.4
vs History
92
vs Industry
1
Median 3Y
255.2
Median 5Y
197.1
Industry
5.2
vs History
vs Industry
Median 3Y
-32.4
Median 5Y
-34.5
Industry
13.5
Forward
-174
vs History
vs Industry
Median 3Y
-30.5
Median 5Y
-32.3
Industry
16.8
Forward
-130.8
vs History
vs Industry
Median 3Y
-39.3
Median 5Y
-41.7
Industry
15.2
vs History
vs Industry
Median 3Y
-37
Median 5Y
-40.1
Industry
19.3
vs History
98
vs Industry
3
Median 3Y
22.9
Median 5Y
24.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Oscotec Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Oscotec Inc
KOSDAQ:039200
929.3B KRW 29.1 -190.4 -208.6 -140.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/S Multiple
Revenue Growth P/S to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average P/S: 382 944.6
29.1
1 960%
0
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.5
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
4
13%
0.3
US
Merck & Co Inc
NYSE:MRK
4
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average P/E: 32.3
Negative Multiple: -190.4
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average EV/EBITDA: 459.5
Negative Multiple: -208.6
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average EV/EBIT: 2 011.2
Negative Multiple: -140.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top